alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 4.50


 








[*] Represents material that has been omitted and will be filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment under Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.







AMENDMENT NO. 1 TO LICENSE AGREEMENT







THIS AMENDMENT NO. 1 (“Amendment”) is entered into effective as of June 18th, 2018 (the “Amendment Effective Date”) by and between BioLineRx Ltd. (“BioLine”) and Wartner Europe BV (“Perrigo”).







PREFACE:








	A.	
BioLine and Perrigo entered into a License Agreement dated as of December 22, 2014 (the “Agreement”).













	B.	
The Parties now wish to amend certain provisions of the Agreement.












Now therefore, the Parties hereby agree as follows:








	1.	
Section 3.1 of the Agreement is hereby deleted in its entirety and replaced with the following:













		3.1          	a.          	With respect to the Licensed Products referred to in Section 7.2, in consideration for the exclusive license granted to Licensee under Section 2.1, for each Licensed Product unit sold by Licensee and its Sublicensees in a given calendar quarter, Licensee will pay Licensor an amount equal to [*].











		b.	
For the purpose of this Agreement, [*].













	2.	
Subsections (a) and (b) of Section 3.2 are hereby deleted in their entirety and replaced with the following: [*]













	3.	
Section 3.3 is hereby deleted in its entirety and not replaced.













	4.          	(a)          	In Section 4.1, the sentence “Licensor has the right to examine Records that were created within five (5) years of the date of Licensor’s request” is hereby amended to read “Licensor has the right to examine Records that were created within seven (7) years of the date of Licensor’s request.”











		(b)	
In Section 4.2, the reference to “five (5) years” in the second line is hereby amended to “seven (7) years.”













	5.	
In Section 7.2(a), [*]













	6.	
Following the Amendment Effective Date, if Perrigo desires to add one or more countries to the Territory, it shall notify BioLine of such desire, and the Parties shall negotiate in good faith as to whether and on what terms such country(ies) will be added to the Territory.













	7.	
Capitalized terms used but not defined herein shall have the meanings set out in the Agreement.  Except as otherwise specifically agreed in this Amendment, the existing terms of the Agreement shall remain in full force and effect.













	8.	
This Amendment shall be binding upon the parties once executed by all parties and shall enter into force and become effective as of the Amendment Effective Date first written above.












[signature page follows]
















IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their duly authorized representatives as of the Amendment Effective Date.


 


	
BioLineRx Ltd.


 


By: /s/ Philip Serlin




 Name: Philip Serlin




 Title: Chief Executive Officer

	
Wartner Europe BV


 


By: /s/ Christophe Van Damme




 Name: Christophe Van Damme




 Title: Director





 


2
#### Louis GRAMMAR, Appellant, v. BUILDERS BRICK & STONE COMPANY, a Corporation, Appellee.

No. 12821.

Court of Civil Appeals of Texas. San Antonio.

March 23, 1955.

Guy Bonham, San Antonio, for appellant.

Roemer & Rutland, San Antonio, for appellee.

' NORVELL, Justice.

This is an appeal from a county court judgment rendered in favor of appellee and against appellant for the sum of $301.64. The trial judge upon request filed full and complete findings of fact and conclusions of law. Appellee attacks a number of these findings as being without support in the evidence. Certain findings relate to the history of the controversy and are not deemed controlling. Such facts as are mentioned in this opinion have support in the evidence and appellant’s points asserting the contrary are overruled. The controlling issue presented by this appeal relates to the applicability of the statute of frauds to the agreement sued upon. Article 3995, § 2, Vernon’s Ann.Tex.Civ.Stats.

Marvin J. Cooper, a masonry contractor, was engaged in the' construction of houses upon lands owned by appellant, Louis Grammar. He secured ter.tain building materials from appellee, Builders Brick & Stone Company. The account became delinquent and appellee prepared to file a materialman’s lien; against appellant’s property. Upon learning of this contemplated action, appellant called at appellee’s place of business and talked with Miss Hope Lindsay, the office manager of Builders Brick and Stone. Company, who served as secretary to the general manager, Walter L. Cornelius. Grammar told Miss Lindsay that if no lien were filed, he would pay the account. ' •'

Further negotiations between Grammar and appellee’s attorney finally resulted in an agreement whereby Grammar agreed to pay the balance of the Cooper account, provided no lien was filed affecting his property and a ten per cent discount was allowed. No lien was filed, but appellant has failed to pay the account, which when discounted, according to the agreement, amounted to $301.64, for which sum judgment was rendered, upon the conclusions of the trial court that :

T. Appellant had agreed to pay off the Cooper indebtedness' in consideration of appellee’s not filing its statutory lien.

*186*2.*The primary objective to be accomplished by appellant’s promise was to induce appellee to forego the filing of a statutory lien against property owned by appellant.

3. The . oral agreement between appellant and appellee was an original rather than a collateral, undertaking, which was supported by a .valid ■ consideration and hence not within the statute of frauds.

The conclusions of the trial judge are supported by his fact findings, which in turn are supported by sufficient evidence. We have had occasion to examine at length the matter of original, and .collateral agree-, ments with reference to Section 2 of the statute of frauds, Article 3995, and need not extend this opinion further than to call attention to Shahan-Taylor Co. v. Foremost Dairies, Tex.Civ.App., 233 S.W.2d 885, and the authorities therein cited.

The judgment is affirmed.
EXHIBIT 31.1

                                 CERTIFICATIONS

I,  Timothy  Rosen, Chief Executive Officer of VerticalBuyer, Inc. certify that:

     1.     I  have  reviewed  this  quarterly  report  for  the  quarter  ended
September  30,  2001  on  Form  10-QSB  of  VerticalBuyer,  Inc.

     2.     Based  on  my  knowledge, this quarterly report does not contain any
untrue  statement  of a material fact or omit to state a material fact necessary
to  make  the  statements  made,  in light of the circumstances under which such
statements  were made, not misleading with respect to the period covered by this
quarterly  report;

     3.     Based on my knowledge, the financial statements, and other financial
information  included  in  this quarterly report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods presented in this quarterly report;

     4.     The  registrant's  other certifying officers, and I, are responsible
for  establishing and maintaining disclosure controls and procedures (as defined
in  Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  have:

     a) Designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  know  to  us  by others within those entities, particularly during the
period  in  which  this  quarterly  report  is  being  prepared;

     b)  Evaluated the effectiveness of the registrant's disclosure controls and
procedures  and  presented  in  this  quarterly report our conclusions about the
effectiveness  of  the  disclosure controls and procedures, as of the end of the
period  covered  by  this  report  based  on  our  evaluation.

     c)  Disclosed  in this quarterly report any change in the issuer's internal
control over financial reporting that occurred during the period covered by this
quarterly  report  that  has  materially  affected,  or  is reasonably likely to
materially  affect,  the registrant's internal control over financial reporting;
and

     5.     The  registrant's  other  certifying  officers and I have disclosed,
based  on our most recent evaluation, to the registrant's auditors and the audit
committee  of  registrant's  board  of  directors  (or  persons  performing  the
equivalent  functions):

     a)  All  significant  deficiencies  in  the design or operation of internal
controls  which  are  reasonably  likely  to  adversely  affect the registrant's
ability  to  record,  process,  summarize  and report financial information; and

     b)  Any  fraud,  whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls over
financial  reporting.

Date:  July 2, 2004

                                                /s/ Timothy  Rosen
                                                -------------------------
                                                Timothy  Rosen
                                                Chief  Executive  Officer


                                        8
<PAGE>